Functional antagonism of μ-, δ- and κ-opioid antinociception by orphanin FQ

Neuroscience Letters

Volumn 214, Issue 2-3, 1996, Pages 131-134

  Mogil, Jeffrey S ^a,b   Grisel, Judith E ^a   Zhangs, Ge ^a   Belknap, John K ^a   Grandy, David K ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Anti opiate; Delta; Kappa; LC132 receptor; Mu; Orphanin FQ; Pain inhibition

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; DELTA OPIATE RECEPTOR; ENKEPHALIN; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; KAPPA OPIATE RECEPTOR; MORPHINE; MU OPIATE RECEPTOR; NOCICEPTIN;

ADOLESCENT; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FEMALE; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; MOUSE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL;

EID: 0030598929     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3940(96)12917-7     Document Type: Article

References (19)

1. [1] Ben-Bassat, J., Peretz, E. and Sulman, F.G., Analgesimetry and ranking of analgesic drugs by the receptacle method, Arch. Int. Pharmacodyn. Ther., 122 (1959) 434-447.
2. [2] Brase, D.A., Loh, H.H. and Way, E.L., Comparison of the effects of morphine on locomotor activity, analgesia and primary and protracted physical dependence in six mouse strains, J. Pharmacol. Exp. Ther., 201 (1977) 368-374.
3. [3] Bunzow, J.R., Saez, C., Mortrud, M., Bouvier, C., Williams, J.T., Low, M. and Grandy, D.K., Molecular cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not a μ, δ or κ opioid receptor type, FEBS Lett., 347 (1994) 284-288.
4. 3 subtype, J. Pharmacol. Exp. Ther., 251 (1989) 461-468.
5. [5] Fang, F.G., Fields, H.L. and Lee, N.M., Action at the mu receptor is sufficient to explain the supraspinal analgesic effect of opiates, J. Pharmacol. Exp. Ther., 238 (1986) 1039-1044.
6. [6] Fillingim, R.B. and Maixner, W., Gender differences in the responses to noxious stimuli, Pain Forum, 4 (1995) 209-221.
7. [7] Grisel, J.E., Mogil, J.S., Belknap, J.K., Grandy, D.K., Orphanin FQ is a supraspinal, but not a spinal, anti-opioid peptide, NeuroReport, in press.
8. [8] Ho, I.K., Loh, H.H. and Way, E.L., Morphine analgesia, tolerance and dependence in mice from different strains and vendors, J. Pharm. Pharmacol., 29 (1977) 583-584.
9. [9] Laursen, S.E. and Belknap, J.K., Intracerebroventricular injections in mice: some methodological refinements, J. Pharmacol. Methods, 16 (1986) 355-357.
10. 2]deltorphin II in mice: evidence for delta receptor subtypes, J. Pharmacol. Exp. Ther., 258 (1991) 583-587.
11. 1 receptor, Nature, 377 (1995) 532-535.
12. [12] Mogil, J.S., Grisel, J.E., Reinscheid, R.K., Civelli, O., Belknap, J.K., Grandy, D.K., Orphanin FQ is a functional anti-opioid peptide, Neuroscience, in press.
13. [13] Pasternak, G.W., Pharmacological mechanisms of opioid analgesics, Clin. Neuropharmacol., 16 (1993) 1-18.
14. [14] Pasternak, G.W. and Snyder, S.H., Identification of novel high affinity opiate receptor binding in rat brain, Nature, 253 (1975) 563-565.
15. [15] Pick, C.G., Cheng, J., Paul, D. and Pasternak, G.W., Genetic influences in opioid analgesic sensitivity in mice, Brain Res., 566 (1991) 295-298.
16. [16] Reinscheid, R.K., Nothacker, H.-P., Bourson, A., Ardati, A., Henningsen, R.A., Bunzow, J.R., Grandy, D.K., Langen, H., Monsma, F.J. and Civelli, O., Orphanin FQ: a novel neuropeptide which is a natural ligand of an opioid-like G protein-coupled receptor, Science, 270 (1995) 792-794.
17. [17] Sutters, K.A., Miaskowski, C., Taiwo, Y.O. and Levine, J.D., Analgesic synergy and improved motor function produced by combinations of μ-δ and μ-κ-opioids, Brain Res., 530 (1990) 290-294.
18. 2-opioid receptors in the brain and spinal cord, respectively, Eur. J. Pharmacol., 242 (1993) 145-150.
19. [19] Walker, M.J.K., Le, A.D., Poulos, C.X. and Cappell, H., Chronic selective blockade of μ opioid receptors produces analgesia and augmentation of the effects of a κ agonist, Brain Res., 538 (1991) 181-186